Dr. Jeffrey Meyerhardt is the Clinical Director of the Gastrointestinal Cancer Center and Senior Physician at Dana-Farber Cancer Institute. In his research, Dr. Meyerhardt, who also is an Associate Professor of Medicine at Harvard Medical School and co-leader of the Center for Colon and Rectal Cancer at Dana-Farber/Brigham and Women’s Cancer Center, focuses primarily on the influence of diet and lifestyle on outcomes among patients with colorectal cancer (CRC). Dr. Meyerhardt is principal investigator of a national clinical trial testing celecoxib as adjunctive therapy to standard treatment for stage III CRC, and recently became co-chair of the GI Committee for the NCI cooperative group Alliance. He earned his MD from Yale School of Medicine, then completed a residency in internal medicine at Beth Israel Deaconess Medical Center and a medical oncology fellowship at Dana-Farber. He joined the Gastrointestinal Cancer Center at Dana-Farber in 2002 and the faculty at Harvard Medical School in 2002.
Please like & share: